Pay in 4 interest-free payments of $6.33 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
The second therapy, MK-1167, is an investigational oral treatment that is taken along with donepezil, an approved acetylcholineraste inhibitor, to improve symptoms of Alzheimers
Why Does Receptor Selectivity Matter in Study Design
Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis
TRIUMPH-2 (NCT05929079) will assess bodyweight change in people with overweight/obesity and T2D and include a subset of participants with OSA, in which AHI will also be investigated as a primary endpoint
1000 -
US$ 20.24
US$ 20.80
US$ 29.13
US$ 22.53
US$ 21.49
US$ 21.38
US$ 24.85
US$ 21.62
US$ 27.61
US$ 27.02
